About | Followers 17 | Exhibitors | Speakers 10 | Reviews | Deals |
This program led by Andrew D. Zelenetz, MD, PhD from Memorial Sloan Kettering Cancer Center discusses treatment and supportive care for hematologic malignancies. It's approved for credits for physicians, nurses, pharmacists, and other oncology professionals.
Listed In
Timings09:00 AM-06:00 PM (expected)Not Verified | Entry FeesPaid Ticket Check Official Website |
Estimated Turnout1000 Delegates 32 Exhibitors | Event TypeConference |
EditionsSep 2023 Interested+5 more editions Frequency Biennial | Official LinksWebsiteContactsReport Error Claim this event |
Organizer![]() Queries about the event?
Ask Organizer
|
EditionSep 2023
How would you like to participate in this event?
Followers [ Users who have shown interest for this Event ] Join Community Invite
Sort By
Frequently Asked Questions Contact Organizer
How many people are planning to attend the event?
Hilton San Francisco Union Square expects about 1000 people to attend the conference NCCN Annual Congress: Hematologic Malignancies.
Helpful
How many exhibitors are planning to attend the event?
NCCN Annual Congress: Hematologic Malignancies brings around 32 exhibitors to participate in the event.
Helpful
Can I get a list of speakers participating in the event?
Can I get a list of exhibitors participating in the event?
Write a Review
Add Your ReviewSpeakers (past edition)
37.785901-122.410833
Venue Map & Directions

333 OFarrell St San Francisco CA 94102
USA
More Events in San Francisco
![]() | TCT Conference San Francisco, USA |
Oct 262023 | Women As Leaders Conference San Francisco, USA |
Jan 302024 | SPIE Quantum West San Francisco, USA |
Feb 192024 | Messaging, Malware and Mobile Anti-Abuse Working Group General Meeting San Francisco, USA |
Mar 122024 | Future of Low-Code Platform for Businesses Summit (US Edition) San Francisco, USA |